Abstract
Background:
Access to contraception is a vital component of preventing unintended pregnancies. This study was conducted to assess the prevalence of and factors associated with U.S. women's difficulty accessing prescription contraception (pill, patch, or ring).
Materials and Methods:
We performed a nationally representative survey of adult women at risk of unintended pregnancy (aged 18–44, not pregnant or seeking pregnancy, sexually active, not sterilized) using a probability-based web panel. In November to December 2011, 2046 women completed the survey. Weighted proportions were calculated and logistic regression was used to identify covariates associated with difficulty obtaining or refilling prescription contraception.
Results:
A total of 1385 (68%) women had ever tried to get a prescription for hormonal contraception. Among this population, 29% reported ever having problems obtaining a prescription or refills. In multivariable regression, uninsured (vs. privately insured) and Spanish-speaking (vs. English-speaking) women were significantly more likely to report difficulties; women with a high school degree and those with some college (vs. a college degree or higher) were significantly less likely to report difficulty. Difficulties included cost barriers or lack of insurance (14%), challenges obtaining an appointment or getting to a clinic (13%), the clinician requiring a clinic visit, exam, or Pap smear (13%), not having a regular doctor/clinic (10%), difficulty accessing a pharmacy (4%), and other reasons (4%).
Conclusions:
One-third of adult U.S. women who have ever tried to obtain prescription contraception reported access barriers. While the Affordable Care Act may resolve some of these issues, these data indicate that additional factors may still need to be addressed.
Introduction
P
Oral contraceptives, used by 10.6 million women, are the most widely used contraceptive method in the United States. 1 Other prescription-based hormonal contraceptives, including the contraceptive patch and ring, are also commonly used. 1 These methods are 91% effective with typical use and 99% effective with perfect use. 4 However, limited research indicates that the prescription requirement for these methods may be a barrier to uptake and consistent use for some women. 5 –7
Studies have shown that not having time for medical visits and the cost of a doctor's visit can make it difficult for women to obtain a prescription or refill for contraception. 5,6 Other research has found that running out of pills and not being easily able to resupply is a common reason for inconsistent pill use. 7 However, little is known about the extent of these difficulties and who is most affected by them. We aimed to contribute to the literature by exploring the prevalence of and factors related to difficulties in obtaining prescriptions for hormonal contraceptive methods among adult women in the United States.
Materials and Methods
We conducted a nationally representative survey of adult U.S. women who were at risk of unintended pregnancy to explore their experiences accessing prescription-based hormonal contraception (i.e., pill, patch, and ring). These data were collected as part of a larger survey that included questions about women's support for over-the-counter access to oral contraception in the United States. 8 Women living in the United States, aged 18–44, who spoke English or Spanish, and who were considered at risk for unintended pregnancy (i.e., they had had heterosexual intercourse in the past 12 months, were not pregnant or trying to get pregnant, had not delivered a baby in the past 2 months, and were not protected by male or female sterilization 6 ) were eligible to participate. The survey was conducted in English or Spanish and administered by GfK using their KnowledgePanel, a nationally representative, probability-based, nonvolunteer, online household panel. 9 The methodology of the panel and administration of this survey have been previously described. 8 The study was approved by the Allendale Investigational Review Board, and the survey was fielded in November to December 2011.
GfK provided a data file with weighting variables that incorporated design-based weights. These weights accounted for panel recruitment and were benchmarked against the most recent Current Population Survey's demographic and geographic distributions for noninstitutionalized women aged 18–44 10 and Pew Hispanic Center Survey's Spanish language distributions. 11
The survey included questions about participants' background characteristics, contraceptive use, and experiences obtaining and filling a prescription for hormonal contraception. Participants were asked if they had ever tried to get a prescription for a hormonal birth control method, such as birth control pills, the patch, or the ring. If they said yes, they were asked about their ease of access to these methods. Our outcome of interest was difficulty obtaining or refilling a prescription for hormonal contraception (1 = yes, 0 = no). Women were considered to have had difficulty if they answered “somewhat difficult” or “very difficult” (opposed to “somewhat easy” or “very easy”) to the question, “In general, how easy or difficult was it for you to get a prescription for a birth control method (birth control pills, the patch, or the ring)?” and/or if they answered yes (opposed to no) to the question, “Did you ever run out of your birth control method (birth control pills, the patch, or the ring) and have problems getting more supplies when you needed them?” and/or if they answered yes to any specific difficulties obtaining or refilling a prescription for hormonal birth control that was provided in a list of response options or if they wrote in other difficulties not listed.
Data analyses were conducted using the survey function within Stata 12.0 (Stata; StataCorp, College Station, TX) to account for complex sampling design. Statistical tests assumed significance at p < 0.05. Univariable and multivariable logistic regression analyses were performed to estimate the odds of difficulty obtaining or refilling a prescription for hormonal contraception by demographic and reproductive background characteristics. All variables were used as binary or categorical predictors, with one category selected as the reference group based on a large sample size and/or meaningful comparison. Missing data were excluded from these analyses. All independent variables shown in Table 1 were included in an initial multivariable regression model. Sequentially, extraneous variables with a p > 0.20 were removed. All variables shown in Table 3 were included in the final model. We used the 2011 Department of Health and Human Services poverty guidelines 12 to convert respondents' income level and the number of people in their household into a dichotomous variable indicating poverty status (≤200% federal poverty level or >200% federal poverty level). The specific problems related to obtaining or refilling a prescription that women reported, which they selected from a list of response options or wrote in for other reasons not listed, were coded thematically into the following categories: challenges related to obtaining an appointment or getting to a clinic; cost barriers or lack of insurance coverage; not having a regular doctor or clinic; difficulty accessing a pharmacy; the clinician requiring a clinic visit, exam, or Pap smear before providing refills; and other reasons.
Not all n's sum to total due to missing data. Bolded p-values indicate <0.05.
Results
Sample characteristics
Of the 7989 women invited to participate in the survey, 4487 completed the initial screening, and 2120 were eligible. Of those eligible, 2046 (96.5%) consented and provided data. The final sample for the analyses in this study consisted of the 1385 women (68%) who had ever tried to obtain a prescription for hormonal birth control and reported on ease of access. Among these women, 29% were aged 18–24, 42% were aged 25–34, and 30% were aged 35–44 (range 18–44). Roughly one-quarter had a high school degree or less, 38% had some college, and 39% had a college degree. Three-quarters of participants were non-Hispanic white, 11% Hispanic, 9% non-Hispanic black, 4% non-Hispanic Asian or Pacific Islander, and 3% identified as another race or ethnicity (including those who reported more than one race [2%] and other race/ethnicity [1%]). Four percent of respondents completed the survey in Spanish. Half were married, and 38% had incomes at or below 200% of the federal poverty level. Most women (72%) had private health insurance, 14% were uninsured, and 14% had public insurance (Table 1).
Experiences accessing prescription hormonal contraception
Twenty-nine percent (n = 400) of women who had ever tried to obtain a prescription for hormonal contraception reported difficulties obtaining or refilling a prescription. This included 3% who reported that it was somewhat or very difficult to get a prescription for hormonal birth control and 18% who had ever run out of hormonal birth control and had problems resupplying; the remaining women reported experiencing specific barriers to prescription access. The most commonly cited barriers to prescription access were cost barriers or lack of insurance coverage (14%, including difficulty paying for the method or appointment, insurance not covering the method, and not having insurance), challenges obtaining an appointment or getting to a clinic (13%, including difficulties getting to a clinic, obtaining an appointment, contacting the doctor's office, or getting time off from work or school; office hours not being convenient; and it being a hassle), and the clinician requiring a clinic visit, exam, or Pap smear before providing a refill (13%). Additional challenges included not having a regular doctor or clinic (10%), difficulty accessing a pharmacy (4%, including challenges getting to the pharmacy or pharmacy hours not being convenient), and other reasons (4%, including not knowing where to get a method, the healthcare provider not prescribing the method, mail-order prescription delays and other related challenges, not wanting parents to find out about method use, and the pharmacy being out of stock, among others; Table 2).
CI, confidence interval.
In univariable analyses, higher proportions of women under age 35 (31%–32%), women with less than a high school degree (48%), Hispanic women (48%), Spanish speakers (68%), unmarried cohabitating women (40%), women whose incomes were ≤200% of the federal poverty level (37%), and uninsured women (55%) reported difficulties obtaining or refilling a prescription for hormonal contraceptives compared with their counterparts (Table 1).
In multivariable analysis, Spanish-speaking women (adjusted odds ratio [AOR] 3.4, 95% confidence interval [CI] 1.3–9.0) and uninsured women (vs. privately insured, AOR 3.4, 95% CI 2.1–5.5) both had significantly greater odds of experiencing difficulties with prescription access compared with their counterparts; women with a high school degree (AOR 0.5, 95% CI 0.3–0.9) and those with some college (AOR 0.6, 95% CI 0.4–0.9) were significantly less likely to report difficulty obtaining or refilling a prescription compared with those having a college degree (Table 3).
Bolded p-values indicate <0.05.
All variables shown in the table were included in the multivariable model.
Discussion
One-third of American women who had ever tried to obtain hormonal contraception reported difficulties with prescription or refill access. While the Patient Protection and Affordable Care Act (ACA) will resolve some of these issues through expanding the pool of women with insurance and contraceptive coverage with no copayment, 13 these data indicate that additional barriers still need to be addressed. First, while uninsured women were more likely to report problems obtaining a prescription or refill (55%), 32% of women with public insurance and 24% with private insurance also reported difficulties. Issues independent of insurance status included challenges obtaining an appointment and taking time off from work or school to go to the clinic and inconvenient clinic hours, among others. Another common barrier to hormonal contraceptive access was not wanting a pelvic exam to get a method. Pelvic exams are not required or medically necessary before providing hormonal contraception. 14 Despite this, a recent national survey showed that almost one-third of clinicians always require pelvic examinations before provision of oral contraceptives 15 and most obstetrician–gynecologists believe they are of some importance for assessing hormonal contraception eligibility. 16 While providers have responsibilities to provide recommended health screenings, hormonal contraception should not be contingent on these activities. Education of both providers and patients is needed to ensure hormonal contraception provision is evidence based so as to prevent unnecessary barriers to hormonal methods.
Additionally, the finding related to increased difficulties among Spanish speakers highlights the need to ensure access to language and culturally appropriate services and that non-English speakers receive accurate information about new coverage possibilities under the ACA. However, undocumented and recent immigrants are not eligible for many of the benefits under the ACA 17 and will continue to face barriers accessing contraception. Efforts to address this coverage gap are needed. The decreased barriers reported among women with a high school degree or some college compared with those with a college degree are surprising and should be explored further in future research. The finding may reflect easier access to healthcare services for those that were still in school at the time of the survey.
An additional means of alleviating barriers to these methods is to make oral contraceptives available over the counter. Removal of the prescription requirement for the pill has been shown to be safe, 18 –20 effective, 21 and acceptable to women. 8 As a result, the American College of Obstetricians and Gynecologists issued a Committee Opinion in 2012 supporting over-the-counter access to the pill. 22 If priced affordably and covered by insurance without a prescription requirement, over-the-counter availability for oral contraception could expand access for both uninsured and insured women who face obstacles related to the prescription requirement.
This study has several limitations. The data were collected in 2011 before the contraceptive coverage guarantee under the ACA began to take effect and may not reflect the current experience of American women. However, the study provides a useful baseline assessment of barriers to prescription hormonal contraception to which future studies post-ACA implementation may be compared. In addition, the measures of barriers to access do not specify timing and we cannot be certain if the participant experienced the barrier recently or in the past. Another potential limitation is the risk of nonparticipation bias as only 56% of women initially contacted completed the screening questions. However, panel members were not informed of the survey topic until they completed screening, and this completion rate is similar to surveys on other topics using this panel. 23 –26 Finally, the survey excluded adolescents; given that this population may face particular barriers accessing contraception, future research should focus on women under age 18.
Conclusions
Barriers to hormonal contraceptive methods are common among U.S. women. Expanded insurance coverage from the ACA may alleviate some of these problems, but additional efforts are needed, including education of women and providers on hormonal contraception guidelines, and ensuring health resources and services are also tailored to non-English-speaking women. Finally, the removal of the prescription requirement for oral contraceptives may also reduce access barriers and facilitate consistent contraceptive use.
Footnotes
Acknowledgments
This study was funded by grants from the Society of Family Planning and The William and Flora Hewlett Foundation. The views and opinions expressed are those of the authors and do not necessarily represent the views and opinions of the Society of Family Planning or The William and Flora Hewlett Foundation.
Author Disclosure Statement
No competing financial interests exist.
